Literature DB >> 12059846

Induction of mania and cycle acceleration in bipolar disorder: effect of different classes of antidepressant.

R T Joffe1, G M MacQueen, M Marriott, J Robb, H Begin, L T Young.   

Abstract

OBJECTIVE: To assess the effect of different antidepressants on induction of mania and cycle acceleration, commonly accepted unwanted effects of antidepressant treatment for acute bipolar depression. There is, however, the suggestion that certain classes of antidepressants may be less likely than others to cause these unwanted effects.
METHOD: We conducted a prospective, open, naturalistic, life charting study to assess the occurrence of onset of mania and cycle acceleration attributable to two antidepressant classes: selective serotonin reuptake inhibitors (SSRIs) and bupropion.
RESULTS: No difference was found between the two drug classes for either antidepressant-induced mania or cycle acceleration. Antidepressant-induced mania was much more likely to occur in bipolar I rather than bipolar II patients. The overall occurrence of induction of mania and cycle acceleration was low across antidepressant classes.
CONCLUSION: These findings suggest that there is probably no difference in the risk of antidepressant-induced mania or cycle acceleration across commonly used classes of antidepressants for the treatment of bipolar depression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12059846     DOI: 10.1034/j.1600-0447.2002.02360.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  13 in total

Review 1.  Review of evidence for use of antidepressants in bipolar depression.

Authors:  Shane J McInerney; Sidney H Kennedy
Journal:  Prim Care Companion CNS Disord       Date:  2014-10-16

2.  Course of illness following prospectively observed mania or hypomania in individuals presenting with unipolar depression.

Authors:  Jess G Fiedorowicz; Jean Endicott; David A Solomon; Martin B Keller; William H Coryell
Journal:  Bipolar Disord       Date:  2012-07-20       Impact factor: 6.744

3.  Practical Clues to Early Recognition of Bipolar Disorder: A Primary Care Approach.

Authors:  Alan C Swann; Barbara Geller; Robert M Post; Lori Altshuler; Kiki D Chang; Melissa P Delbello; Christopher Reist; Iver A Juster
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

Review 4.  The neurobiology of the switch process in bipolar disorder: a review.

Authors:  Giacomo Salvadore; Jorge A Quiroz; Rodrigo Machado-Vieira; Ioline D Henter; Husseini K Manji; Carlos A Zarate
Journal:  J Clin Psychiatry       Date:  2010-05-04       Impact factor: 4.384

5.  Genetic features of antidepressant induced mania and hypo-mania in bipolar disorder.

Authors:  Alessandro Serretti; Paola Artioli; Raffaella Zanardi; Cristina Lorenzi; David Rossini; Cristina Cusin; Alessia Arnoldi; Marco Catalano
Journal:  Psychopharmacology (Berl)       Date:  2004-07-10       Impact factor: 4.530

6.  Burden of illness in bipolar depression.

Authors:  J Sloan Manning
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

7.  A preliminary study of sustained-release bupropion for smoking cessation in bipolar disorder.

Authors:  Andrea H Weinberger; Jennifer C Vessicchio; Kristi A Sacco; Cerissa L Creeden; K N Roy Chengappa; Tony P George
Journal:  J Clin Psychopharmacol       Date:  2008-10       Impact factor: 3.153

8.  Management of Bipolar II Disorder.

Authors:  Michael M C Wong
Journal:  Indian J Psychol Med       Date:  2011-01

9.  Risk factors of cycle acceleration in acutely admitted patients with bipolar disorder.

Authors:  P I Finseth; G Morken; U F Malt; O A Andreassen; A E Vaaler
Journal:  Acta Psychiatr Scand       Date:  2014-06-24       Impact factor: 6.392

Review 10.  Significant Treatment Effect of Bupropion in Patients With Bipolar Disorder but Similar Phase-Shifting Rate as Other Antidepressants: A Meta-Analysis Following the PRISMA Guidelines.

Authors:  Dian-Jeng Li; Ping-Tao Tseng; Yen-Wen Chen; Ching-Kuan Wu; Pao-Yen Lin
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.